A new study from the USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has identified a previously unrecognized disparity in survival in hepatocellular carcinoma (HCC) patients across all major racial/ethnic groups. The results, published in the Journal of the American Cancer Institute, show that compared to those born in the United States, immigrants are more likely to survive the disease.
The study is one of the first to robustly address nativity status as a predictor of overall survival for adults with HCC. Its findings indicate that greater care may be needed when addressing treatment plans for patients born in the U.S.
To read the full story, click here.